News

Published on 19 Jan 2023 on Benzinga via Yahoo Finance

India-Based Sun Pharma Scoops Up Concert Pharmaceuticals For $576M Plus Milestones


Article preview image

Sun Pharmaceutical Industries Limited, India's top pharmaceutical company, has agreed to acquire Concert Pharmaceuticals Inc (NASDAQ: CNCE) for an upfront payment of $8.00 per share, or $576 million in equity value.Concert stockholders will also receive a non-tradeable contingent value right (CVR) entitling holders to receive up to an additional $3.50 per share in cash, payable upon deuruxolitinib achieving certain net sales milestones within specified periods.Concert is a late-stage biotechnology company, with its lead product candidate deuruxolitinib – an oral inhibitor of Janus kinases JAK1 and JAK2 for Alopecia Areata, an autoimmune dermatological disease characterized by patchy hair loss.Concert has completed the evaluation of the efficacy and safety of deuruxolitinib in adult patients with moderate to severe Alopecia Areata in its THRIVE-AA Phase 3 study, and two open-label, long-term extension studies are ongoing.Sun Pharma's immediate focus would be to follow Concert's plan to submit a marketing application to the FDA in 1H of 2023.The transaction is expected to be completed in the first quarter of 2023.Sun Pharma had net cash of $1.6 billion, and Concert had approximately $148.9 million in cash, cash equivalents & investments as of September 30, 2022.Price Action: CNCE shares are up 19.27% at $8.23 during the premarket session on the last check Thursday.

Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.

NSE.SUNPHARMA price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
30 Richest People in Asia in 2024

In this article, we discuss the 30 richest people in Asia in 2024. To skip the detailed analysis,...

Insider Monkey via Yahoo Finance 12 May 2024

30 Most Valuable Drug Companies in 2024

In this article, we will take a look at the 30 most valuable drug companies in 2024. If you want ...

Insider Monkey via Yahoo Finance 10 Feb 2024

30 Largest Pharmaceutical Companies in the World

In this article, we will be taking a look at the 30 largest pharmaceutical companies in the world...

Insider Monkey via Yahoo Finance 12 Dec 2023

Opioid Market Size, Growth, Segments, Revenue, Manufacturers and 2032 Forecast

The report provides a massive information concerning the outstanding, first-time present and...

Digital Journal 25 Jan 2023

India’s Sun Pharma to acquire U.S.-based Concert for $576 million

(Reuters) -Sun Pharmaceutical Industries Limited said on Thursday it will acquire U.S.-based Conc...

WHTC 1450 Holland 19 Jan 2023

India-Based Sun Pharma Scoops Up Concert Pharmaceuticals For $576M Plus Milestones

Sun Pharmaceutical Industries Limited, India's top pharmaceutical company, has agreed to acquire ...

Benzinga via Yahoo Finance 19 Jan 2023

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) Stock Is Going Strong But Fundamentals Look...

Taro Pharmaceutical Industries' (NYSE:TARO) stock is up by a considerable 9.5% over the past mont...

Simply Wall St. via Yahoo Finance 5 Jul 2022

Explained | Pfizer v/s Merck: New anti COVID pill and its comparison

While Merck was the first to roll out its anti-COVID therapy, called molnupiravir, Pfizer has...

MSN News 8 Nov 2021

Merck Teams Up With Five Indian Generic Players To Expand COVID-19 Drug Access, Production

Merck & Co Inc (NYSE: MRK) has partnered with five Indian generic drugmakers to expand production...

Benzinga via Yahoo Finance 21 Apr 2021

What Kind Of Shareholders Own Taro Pharmaceutical Industries Ltd. (NYSE:TARO)?

If you want to know who really controls Taro Pharmaceutical Industries Ltd. (NYSE:TARO), then you...

Simply Wall St. via Yahoo Finance 22 Sep 2020